Medifacts Systems Grants Exclusive License for Genetic Test Patent to Mayo Clinic
News Feb 04, 2008
Medifacts Systems, Inc. announces that it has granted an exclusive license for a genetic test patent to Mayo Clinic. The patented test detects Alpha Thalassemia mutations and their use as predictors of blood-related disorders.
The patent is the invention of Lemuel J. Bowie Ph.D., an African American from Vicksburg, Mississippi who was educated at Xavier University in New Orleans, Howard University, and Johns Hopkins. Through this licensing agreement, Mayo Clinic's reference laboratory, Mayo Medical Laboratories will make the test available to patients worldwide.
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.